Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Environmental Research and Public Health|June 13, 2012
Social aspects of suicidal behavior and prevention in early life: a reviewMaya Amitai, Alan Apter
International Journal of Psychiatry in Clinical Practice|September 10, 2016
Levels of depression and satisfaction with life as indicators of health services consumptionRoi Sagy, Maya Amitai, Abraham Weizman, et al.
Harefuah|April 24, 2012
[Autism spectrum disorders: updates and new definitions]Maya Amitai, Miryam Peskin, Doron Gothelf, et al.
Harefuah|February 2, 2013
[Childhood and adolescent-onset schizophrenia: new information and definitions]Maya Amitai, Yonathan Sever, Abraham Weizman, et al.
Experimental Aging Research|November 3, 2015
The Association in Elderly Hospitalized Patients, Between Psychotropic Drugs and Hip Fractures Resulting from FallsDov Aizenberg, Abraham Weizman, Avraham Weiss, et al.
Harefuah|May 6, 2014
[Pharmacogenetics and anxiety disorders: analysis of recent findings]Maya Amitai, Sefi Kronenberg, Tali Cohen, et al.
Psychopathology|November 14, 2017
Nonfunctional Redundant Acts Characterize OCD, Even in OCD-Unrelated Tasks: A Demonstration in Questionnaire CompletionMaya Amitai, Nitzan Arnon, Noa Shaham, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 5, 2020
An increase in IL-6 levels at 6-month follow-up visit is associated with SSRI-emergent suicidality in high-risk children and adolescents treated with fluoxetineMaya Amitai, Michal Taler, Maya Lebow, et al.
Brain, Behavior, and Immunity|December 31, 2019
Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youthMaya Amitai, Michal Taler, Reut Ben-Baruch, et al.
Peerj|January 18, 2018
An exploratory study of adolescent response to fluoxetine using psychological and biological predictorsAda H Zohar, Tamar Eilat, Maya Amitai, et al.
Pageof 2